HUTCHMED (China) Statistics
Total Valuation
HCM has a market cap or net worth of $2.41 billion. The enterprise value is $1.14 billion.
| Market Cap | 2.41B |
| Enterprise Value | 1.14B |
Important Dates
The last earnings date was Thursday, July 30, 2026, before market open.
| Earnings Date | Jul 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HCM has 869.07 million shares outstanding. The number of shares has increased by 0.02% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 869.07M |
| Shares Change (YoY) | +0.02% |
| Shares Change (QoQ) | -0.04% |
| Owned by Insiders (%) | 0.97% |
| Owned by Institutions (%) | 19.03% |
| Float | 522.84M |
Valuation Ratios
The trailing PE ratio is 134.65 and the forward PE ratio is 37.70.
| PE Ratio | 134.65 |
| Forward PE | 37.70 |
| PS Ratio | 4.38 |
| Forward PS | 3.49 |
| PB Ratio | 1.89 |
| P/TBV Ratio | 1.91 |
| P/FCF Ratio | 242.02 |
| P/OCF Ratio | 117.69 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 63.81 |
| EV / Sales | 2.08 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 114.70 |
Financial Position
The company has a current ratio of 5.64, with a Debt / Equity ratio of 0.07.
| Current Ratio | 5.64 |
| Quick Ratio | 5.45 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | 9.50 |
| Interest Coverage | -12.14 |
Financial Efficiency
Return on equity (ROE) is 1.46% and return on invested capital (ROIC) is -1,741.75%.
| Return on Equity (ROE) | 1.46% |
| Return on Assets (ROA) | -1.24% |
| Return on Invested Capital (ROIC) | -1,741.75% |
| Return on Capital Employed (ROCE) | -2.38% |
| Weighted Average Cost of Capital (WACC) | 6.55% |
| Revenue Per Employee | $306,772 |
| Profits Per Employee | $9,991 |
| Employee Count | 1,790 |
| Asset Turnover | 0.31 |
| Inventory Turnover | 10.66 |
Taxes
In the past 12 months, HCM has paid $1.66 million in taxes.
| Income Tax | 1.66M |
| Effective Tax Rate | 8.25% |
Stock Price Statistics
The stock price has decreased by -9.65% in the last 52 weeks. The beta is 0.45, so HCM's price volatility has been lower than the market average.
| Beta (5Y) | 0.45 |
| 52-Week Price Change | -9.65% |
| 50-Day Moving Average | 12.55 |
| 200-Day Moving Average | 13.20 |
| Relative Strength Index (RSI) | 59.20 |
| Average Volume (20 Days) | 94,358 |
Short Selling Information
The latest short interest is 230,030, so 0.22% of the outstanding shares have been sold short.
| Short Interest | 230,030 |
| Short Previous Month | 201,005 |
| Short % of Shares Out | 0.22% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.13 |
Income Statement
In the last 12 months, HCM had revenue of $549.12 million and earned $17.88 million in profits. Earnings per share was $0.10.
| Revenue | 549.12M |
| Gross Profit | 73.10M |
| Operating Income | -34.78M |
| Pretax Income | 20.08M |
| Net Income | 17.88M |
| EBITDA | -20.52M |
| EBIT | -34.78M |
| Earnings Per Share (EPS) | $0.10 |
Balance Sheet
The company has $1.38 billion in cash and $94.51 million in debt, with a net cash position of $1.28 billion or $1.48 per share.
| Cash & Cash Equivalents | 1.38B |
| Total Debt | 94.51M |
| Net Cash | 1.28B |
| Net Cash Per Share | $1.48 |
| Equity (Book Value) | 1.27B |
| Book Value Per Share | 1.45 |
| Working Capital | 1.28B |
Cash Flow
In the last 12 months, operating cash flow was $20.46 million and capital expenditures -$10.51 million, giving a free cash flow of $9.95 million.
| Operating Cash Flow | 20.46M |
| Capital Expenditures | -10.51M |
| Depreciation & Amortization | 14.26M |
| Net Borrowing | -4.84M |
| Free Cash Flow | 9.95M |
| FCF Per Share | $0.01 |
Margins
Gross margin is 13.31%, with operating and profit margins of -6.33% and 3.26%.
| Gross Margin | 13.31% |
| Operating Margin | -6.33% |
| Pretax Margin | 3.66% |
| Profit Margin | 3.26% |
| EBITDA Margin | -3.74% |
| EBIT Margin | -6.33% |
| FCF Margin | 1.81% |
Dividends & Yields
HCM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.02% |
| Shareholder Yield | -0.02% |
| Earnings Yield | 0.74% |
| FCF Yield | 0.41% |
Analyst Forecast
The average price target for HCM is $22.00, which is 55.70% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $22.00 |
| Price Target Difference | 55.70% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (3Y) | 12.36% |
| EPS Growth Forecast (3Y) | -48.36% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HCM has an Altman Z-Score of 4.08 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.08 |
| Piotroski F-Score | 5 |